SARS-CoV-2 Vaccine Acceptability among Patients Treated by Hemodialysis

  • 1 Jeffrey Silberzweig, MD, is Chief Medical Officer, The Rogosin Institute, and Associate Professor of Clinical Medicine, Weill Cornell Medicine, New York, NY, and Co-Chair of the American Society of Nephrology COVID-19 Response Team, Emergency Partnership Initiative.
Restricted access
Save